Oxford Biomedica (OXB) Stock Chart & Stock Price History GBX 295 0.00 (0.00%) As of 05/2/2025 12:39 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock Oxford Biomedica Stock Price Performance 5 Day Performance-0.84%1 Month Performance+11.95%3 Month Performance-28.05%6 Month Performance-28.92%Year-To-Date Performance-29.76%1 Year Performance-10.06% Receive OXB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Oxford Biomedica and its competitors with MarketBeat's FREE daily newsletter. Email Address OXB Stock Chart for Sunday, May, 4, 2025 OXB Chart by TradingView Oxford Biomedica Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/02/2025GBX 295GBX 295GBX 298GBX 28063,639 shs£313.59 million05/01/2025GBX 288.50GBX 295+2.25%GBX 297GBX 287.50124,748 shs£313.59 million04/30/2025GBX 297.50GBX 288.50-3.03%GBX 304GBX 283.50121,723 shs£306.68 million04/29/2025GBX 304GBX 297.50-2.14%GBX 307GBX 291207,227 shs£316.25 million04/28/2025GBX 299.50GBX 304+1.50%GBX 306GBX 295483,197 shs£323.16 million04/25/2025GBX 296GBX 299.50+1.18%GBX 309.50GBX 29572,561 shs£318.37 million04/24/2025GBX 297.50GBX 296-0.50%GBX 301.50GBX 29158,248 shs£314.65 million04/23/2025GBX 303.50GBX 297.50-1.98%GBX 309GBX 291114,826 shs£316.25 million04/22/2025GBX 299GBX 303.50+1.51%GBX 307.50GBX 291105,221 shs£322.62 million04/21/2025GBX 299GBX 299GBX 307.50GBX 293.50111,308 shs£317.84 million Get the Latest News and Ratings for OXB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Oxford Biomedica and its competitors with MarketBeat's FREE daily newsletter. 04/18/2025GBX 299GBX 299GBX 307.50GBX 293.50111,308 shs£317.84 million04/17/2025GBX 296.32GBX 299+0.91%GBX 307.50GBX 293.50111,308 shs£317.84 million04/16/2025GBX 301GBX 296.32-1.56%GBX 306GBX 295144,675 shs£314.99 million04/15/2025GBX 290GBX 301+3.79%GBX 305GBX 289.50233,506 shs£319.97 million04/14/2025GBX 280GBX 290+3.57%GBX 296GBX 2861.48 million shs£308.27 million04/11/2025GBX 279.50GBX 280+0.18%GBX 281GBX 268.50198,208 shs£297.64 million04/10/2025GBX 232.50GBX 279.50+20.22%GBX 290.99GBX 2421.26 million shs£297.11 million04/09/2025GBX 255.50GBX 232.50-9.00%GBX 251.50GBX 232.50281,602 shs£247.15 million04/09/2025GBX 255.50GBX 232.50-9.00%GBX 251.50GBX 232.50281,602 shs£247.15 million04/08/2025GBX 247.47GBX 255.50+3.25%GBX 257.50GBX 2421.18 million shs£271.60 million04/08/2025GBX 247.47GBX 255.50+3.25%GBX 257.50GBX 2421.18 million shs£271.60 million04/07/2025GBX 263.50GBX 247.47-6.08%GBX 257.50GBX 241.502.05 million shs£263.06 million04/04/2025GBX 271GBX 263.50-2.77%GBX 356.50GBX 252.79369,936 shs£280.10 million04/03/2025GBX 274.86GBX 271-1.40%GBX 277.34GBX 268161,729 shs£288.08 million Related Companies Oxford Nanopore Technologies Stock Price Chart Genus Stock Price Chart PureTech Health Stock Price Chart Faron Pharmaceuticals Oy Stock Price Chart 4basebio Stock Price Chart Bioventix Stock Price Chart Avacta Group Stock Price Chart hVIVO Stock Price Chart Scancell Stock Price Chart Ondine Biomedical Stock Price Chart Receive OXB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Oxford Biomedica and its competitors with MarketBeat's FREE daily newsletter. This page (LON:OXB) was last updated on 5/4/2025 by MarketBeat.com Staff From Our PartnersTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredWill May start the next "Great Depression?"You probably haven't heard about this yet... But this could be the biggest wealth building opportunity of t...Behind the Markets | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oxford Biomedica plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Oxford Biomedica With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.